Cost-effectiveness of human papillomavirus vaccination in Germany
Abstract Background The aim of this study was to assess the cost-effectiveness of human papillomavirus (HPV) vaccination in addition to the current cervical cancer screening programme in Germany using a dynamic transmission model. Methods Based on a mathematical model simulating the transmission dyn...
Main Authors: | Oliver Damm, Johannes Horn, Rafael T. Mikolajczyk, Mirjam E. E. Kretzschmar, Andreas M. Kaufmann, Yvonne Deleré, Bernhard Ultsch, Ole Wichmann, Alexander Krämer, Wolfgang Greiner |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-09-01
|
Series: | Cost Effectiveness and Resource Allocation |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12962-017-0080-9 |
Similar Items
-
Cancer incidence in Germany attributable to human papillomavirus in 2013
by: Nina Buttmann-Schweiger, et al.
Published: (2017-10-01) -
Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany – a mathematical modelling study
by: Johannes Horn, et al.
Published: (2018-01-01) -
Seroprevalence of mucosal and cutaneous human papillomavirus (HPV) types among children and adolescents in the general population in Germany
by: Anna Loenenbach, et al.
Published: (2022-01-01) -
Epidemiology and cost of seasonal influenza in Germany - a claims data analysis
by: Stefan Scholz, et al.
Published: (2019-08-01) -
A systematic review of the HPV‐attributable fraction of oropharyngeal squamous cell carcinomas in Germany
by: Miriam Reuschenbach, et al.
Published: (2019-04-01)